Allworth Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52.4K | Hold |
790
| – | – | ﹤0.01% | 2438 |
|
|
2026
Q1 | $42.7K | Hold |
790
| – | – | ﹤0.01% | 2439 |
|
|
2025
Q4 | $44.2K | Hold |
790
| – | – | ﹤0.01% | 2282 |
|
|
2025
Q3 | $37.9K | Hold |
790
| – | – | ﹤0.01% | 2296 |
|
|
2025
Q2 | $32.1K | Hold |
790
| – | – | ﹤0.01% | 2212 |
|
|
2025
Q1 | $31.5K | Hold |
790
| – | – | ﹤0.01% | 1797 |
|
|
2024
Q4 | $35.2K | Hold |
790
| – | – | ﹤0.01% | 1763 |
|
|
2024
Q3 | $35K | Hold |
790
| – | – | ﹤0.01% | 1571 |
|
|
2024
Q2 | $32.8K | Hold |
790
| – | – | ﹤0.01% | 1576 |
|
|
2024
Q1 | $34.1K | Sell |
790
-150
| -16% | -$6.46K | ﹤0.01% | 1474 |
|
|
2023
Q4 | $39.1K | Hold |
940
| – | – | ﹤0.01% | 1292 |
|
|
2023
Q3 | $37.4K | Hold |
940
| – | – | ﹤0.01% | 1225 |
|
|
2023
Q2 | $38.5K | Hold |
940
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q1 | $38.5K | Hold |
940
| – | – | ﹤0.01% | 1170 |
|
|
2022
Q4 | $38.5K | Hold |
940
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q3 | $38K | Hold |
940
| – | – | ﹤0.01% | 1059 |
|
|
2022
Q2 | $39K | Hold |
940
| – | – | ﹤0.01% | 991 |
|
|
2022
Q1 | $43K | Hold |
940
| – | – | ﹤0.01% | 952 |
|
|
2021
Q4 | $43K | Hold |
940
| – | – | ﹤0.01% | 886 |
|
|
2021
Q3 | $45K | Buy |
940
+790
| +527% | +$39.3K | ﹤0.01% | 812 |
|
|
2021
Q2 | $8K | Hold |
150
| – | – | ﹤0.01% | 1114 |
|
|
2021
Q1 | $8K | Hold |
150
| – | – | ﹤0.01% | 1044 |
|
|
2020
Q4 | $8K | Hold |
150
| – | – | ﹤0.01% | 900 |
|
|
2020
Q3 | $7K | Hold |
150
| – | – | ﹤0.01% | 792 |
|
|
2020
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 841 |
|
|
2020
Q1 | $5K | Hold |
150
| – | – | ﹤0.01% | 891 |
|
|
2019
Q4 | $7K | Hold |
150
| – | – | ﹤0.01% | 717 |
|
|
2019
Q3 | $5K | Hold |
150
| – | – | ﹤0.01% | 694 |
|
|
2019
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 665 |
|
|
2019
Q1 | $6K | Hold |
150
| – | – | ﹤0.01% | 659 |
|
|
2018
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 624 |
|
|
2018
Q3 | $7K | Hold |
150
| – | – | ﹤0.01% | 613 |
|
|
2018
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 612 |
|
|
2018
Q1 | $6K | Hold |
150
| – | – | ﹤0.01% | 571 |
|
|
2017
Q4 | $7K | Hold |
150
| – | – | ﹤0.01% | 529 |
|
|
2017
Q3 | $6K | Hold |
150
| – | – | ﹤0.01% | 560 |
|
|
2017
Q2 | $6K | Buy |
+150
| New | +$6.32K | ﹤0.01% | 557 |
|
Other funds holding XPH
KWM
FCBT
EP
Allworth Financial's XPH Position: Q2 2026 in Review
Allworth Financial held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2026 at 790 shares worth $52.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2438.
Allworth Financial first reported a position in XPH in Q2 2017 and has held it in 37 quarters since. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.
- Allworth Financial held 790 shares of State Street SPDR S&P Pharmaceuticals ETF worth $52.4K as of Q2 2026.
- Allworth Financial left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2438 holding.
- Allworth Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2017 and has held it in 37 quarters since.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.